Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck Clinical Trials in Vandœuvre-lès-Nancy

Study of TPEx Followed by a Maintenance With Avelumab and Cetuximab in First Line Recurrent or Metastatic Squamous Cell Carcinoma of the H&N